WHO urges action as drug-resistant malaria spreads

September 27, 2012

The World Health Organization said Thursday that governments in the Mekong region must act "urgently" to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar.

There is growing evidence that the is becoming resistant to a frontline treatment, the anti-malarial drug artemisinin, in southern and central Vietnam and in southeastern Myanmar, the WHO said in a statement.

Drug- was found on the Thailand-Cambodia border eight years ago, and has since also been discovered along the Thailand-Myanmar border, according to scientists.

WHO regional director, Shin Young-soo, said countries must "urgently address this issue before we put at risk not only the fragile gains we have made in but also our goal of a malaria-free Western Pacific Region."

Countries in the Mekong region must "intensify and expand" operations to contain and eliminate artemisinin-resistant malaria, Shin said at a WHO regional meeting in Hanoi.

Drug-resistant malaria in Vietnam is mainly concentrated in three central and southern provinces, say health officials, adding that there are a number of key factors which make tackling the problem difficult in the communist country.

The population in the affected provinces are very poor, highly mobile, and have not widely embraced DEET-treated which could reduce malaria infections, according to media reports of a government conference in July.

People in the affected provinces often received outpatient treatment and frequently fail to complete a full course of anti-malarial treatment.

Resistance to does not prevent patients being cured, thanks to other partner drugs, but treatment typically takes a few days instead of 24 hours.

Malaria is a life-threatening disease caused by parasites that are transmitted through the bites of infected mosquitoes.

It killed an estimated 655,000 people in 2010, mostly African children, although mortality rates have fallen sharply over the past decades, according to the WHO.

Explore further: WHO hopeful drug-resistant malaria can be contained

Related Stories

WHO hopeful drug-resistant malaria can be contained

April 24, 2012
The World Health Organisation said Tuesday it was optimistic drug-resistant malaria that has emerged along Thailand's borders with Cambodia and Myanmar could be contained within the region.

Study finds early signs of malaria drug resistance in Africa

April 27, 2012
Africa's deadliest malaria parasite has shown resistance in lab tests to one of the most powerful drugs on the market -- a warning of possible resistance to follow in patients, scientists said Friday.

New artemisinin-based treatment against malaria promising

November 8, 2011
For some time now, artemisinin, derived from a Chinese herb, has been the most powerful treatment available against malaria. To avoid the malaria parasite becoming resistant, the World Health Organisation (WHO) strongly recommends ...

Screening effort turns up multiple potential anti-malaria compounds

August 4, 2011
Numerous potential anti-malarial candidate drugs have been uncovered by investigators from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI), both parts ...

Artemisinin-resistant untreatable malaria increasing rapidly along the Thailand-Myanmar border: study

April 5, 2012
Evidence that the most deadly species of malaria parasite, Plasmodium falciparum, is becoming resistant to the front line treatment for malaria on the border of Thailand and Myanmar (Burma) is reported in The Lancet today. ...

Recommended for you

Four simple tests could help GPs spot pneumonia and reduce unnecessary antibiotics

November 23, 2017
Testing for fever, high pulse rate, crackly breath sounds, and low oxygen levels could be key to helping GPs distinguish pneumonia from less serious infections, according to a large study published in the European Respiratory ...

New approach to tracking how deadly 'superbugs' travel could slow their spread

November 22, 2017
Killer bacteria - ones that have out-evolved our best antibiotics—may not go away anytime soon. But a new approach to tracking their spread could eventually give us a fighting chance to keep their death toll down.

Research points to diagnostic test for top cause of liver transplant in kids

November 22, 2017
Biliary atresia is the most common cause of liver transplants for children in the United States. Now researchers report in Science Translational Medicine finding a strong biomarker candidate that could be used for earlier ...

Metabolites altered in chronic kidney disease

November 22, 2017
Chronic kidney disease (CKD) affects 1 in 7 people in the United States, according to the U.S. National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK). These individuals have a very high risk of cardiovascular ...

Rainfall can indicate that mosquito-borne epidemics will occur weeks later

November 22, 2017
A new study demonstrates that outbreaks of mosquito-borne viruses Zika and Chikungunya generally occur about three weeks after heavy rainfall.Researchers also found that Chikungunya will predominate over Zika when both circulate ...

Alcohol consumption and metabolic factors act together to increase the risk of severe liver disease

November 22, 2017
A new study provides insights into the interaction between alcohol consumption and metabolic factors in predicting severe liver disease in the general population. The findings, which are published in Hepatology, indicate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.